Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Venous Thormboembolism × Enoxaparin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Venous Thrombosis 2 Venous Thromboembolism 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasms 2 Venous Thormboembolism 1 Thrombosis 1 Small Cell Lung Carcinoma 1 Pulmonary Embolism 1 Colorectal Neoplasms 1 Catheter-Related Infections 1 Carcinoma, Pancreatic Ductal 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02706249 2021-07-08

Study Of Weight-Based Versus Standard Dose Enoxaparin Thromboprophylaxis In High-Risk Hospitalized Cancer Patients

Dana-Farber Cancer Institute

Phase 2 Completed

50 enrolled 7 charts

Venous Thormboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡